Rocket Pharmaceuticals (RCKT) Revenue & Revenue Breakdown
Rocket Pharmaceuticals Revenue Highlights
Rocket Pharmaceuticals Revenue by Period
Rocket Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | - |
Rocket Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $10.31M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | - |
Rocket Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MIRM | Mirum Pharmaceuticals | $186.37M | $69.22M |
STRO | Sutro Biopharma | $153.73M | $13.01M |
RGNX | REGENXBIO | $90.24M | $24.20M |
RYTM | Rhythm Pharmaceuticals | $77.43M | $29.08M |
MRUS | Merus | $43.95M | $11.77M |
QURE | uniQure | $15.84M | $2.29M |
MGTX | MeiraGTx | $14.02M | $282.00K |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
CYTK | Cytokinetics | $7.53M | $463.00K |
PLRX | Pliant Therapeutics | $1.58M | - |
VRDN | Viridian Therapeutics | $314.00K | $72.00K |
PCVX | Vaxcyte | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
INZY | Inozyme Pharma | - | - |
DYN | Dyne Therapeutics | - | - |
REPL | Replimune Group | - | - |
RCKT | Rocket Pharmaceuticals | - | - |
SNDX | Syndax Pharmaceuticals | - | $12.50M |
LRMR | Larimar Therapeutics | - | - |
SLDB | Solid Biosciences | - | - |
RCKT Revenue FAQ
What is Rocket Pharmaceuticals’s yearly revenue?
Rocket Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RCKT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Rocket Pharmaceuticals’s quarterly revenue?
Rocket Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). RCKT's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).
What is Rocket Pharmaceuticals’s revenue growth rate?
Rocket Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.